-+ 0.00%
-+ 0.00%
-+ 0.00%

Vivos Therapeutics agrees to exchange up to $4.5 million Streeterville debt into preferred, common stock

PUBT·06/05/2026 12:45:22
Listen to the news
Vivos Therapeutics agrees to exchange up to $4.5 million Streeterville debt into preferred, common stock
  • Vivos Therapeutics signed a binding deal with Streeterville Capital to swap up to USD 4.5 million of senior secured debt into preferred stock and common shares.
  • Streeterville committed to pause debt repayment demands for 90 days once the exchange takes effect.
  • The lender also agreed to halt sales of company securities for 60 days.
  • The exchange hinges on one or more qualifying equity financings acceptable to Vivos.
  • The transaction targets improved stockholders’ equity to support Nasdaq listing compliance, reduced debt service, stronger cash flow, improved liquidity.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606050845PRIMZONEFULLFEED9732471) on June 05, 2026, and is solely responsible for the information contained therein.